相似文献
1
Defective interleukin-1 production by monocytes from patients with malignant disease. Interferon increases IL-1 production.
Cancer Immunol Immunother. 1984;16(3):182-5. doi: 10.1007/BF00205426.
2
Defective interleukin-1 production by natural killer cells of patients with cancer.
Cancer Immunol Immunother. 1985;19(2):148-53. doi: 10.1007/BF00199724.
3
Regulation of interferon production by human monocytes: requirements for priming for lipopolysaccharide-induced production.
J Leukoc Biol. 1991 Aug;50(2):176-81. doi: 10.1002/jlb.50.2.176.
4
5
Cytokine regulation of human monocyte interleukin-1 (IL-1) production in vitro. Enhancement of IL-1 production by interferon (IFN) gamma, tumour necrosis factor-alpha, IL-2 and IL-1, and inhibition by IFN-alpha.
Clin Exp Immunol. 1990 Jun;80(3):435-43. doi: 10.1111/j.1365-2249.1990.tb03306.x.
6
Interleukin 1 production by human monocytes induced in culture with K562 cells.
Res Exp Med (Berl). 1991;191(3):201-8. doi: 10.1007/BF02576675.
7
Reduction of interleukin 1 and interleukin 2 production by patients with advanced cancer.
Braz J Med Biol Res. 1989;22(10):1259-70.
8
Defective interleukin-1 production of monocytes in patients with bladder cancer.
Br J Urol. 1990 Feb;65(2):181-5. doi: 10.1111/j.1464-410x.1990.tb14695.x.
9
Interleukin-1 production by mononuclear cells from rheumatoid synovial effusions.
Cell Immunol. 1988 Jul;114(2):405-23. doi: 10.1016/0008-8749(88)90332-2.
10
Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Interferon-gamma prevents parasite-induced inhibition of interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-alpha and interleukin 1.
J Clin Invest. 1990 Jun;85(6):1914-24. doi: 10.1172/JCI114654.
引用本文的文献
1
An update on human interleukin-1: from molecular biology to clinical relevance.
J Clin Immunol. 1985 Sep;5(5):287-97. doi: 10.1007/BF00918247.
2
Effects of human interleukin-1 on natural killer cell activity: is fever a host defense mechanism for tumor killing?
Yale J Biol Med. 1986 Mar-Apr;59(2):97-106.
3
Defective interleukin-1 production in a familial monocyte disorder with a combined abnormality of mobility and phagocytosis-killing.
Clin Exp Immunol. 1988 Sep;73(3):500-4.
4
Enhanced production of gamma-interferon by therapy with parenteral OK-432 and alpha-interferon in patients with head and neck cancer.
Arch Otorhinolaryngol. 1986;243(5):281-7. doi: 10.1007/BF00460202.
5
The effect of RU 41.740 (Biostim) on the production of interleukin-1 by monocytes and enriched large granular lymphocytes in normals and patients with hepatocellular carcinoma.
Cancer Immunol Immunother. 1986;21(1):26-30. doi: 10.1007/BF00199373.
6
Defective interleukin-1 production by natural killer cells of patients with cancer.
Cancer Immunol Immunother. 1985;19(2):148-53. doi: 10.1007/BF00199724.
7
Effects of L2C leukemia on macrophage-mediated responses.
Cancer Immunol Immunother. 1987;25(2):75-80. doi: 10.1007/BF00199944.
8
Tumour necrosis factor-alpha enhances the cytolytic and cytostatic capacity of interleukin-2 activated killer cells.
Br J Cancer. 1989 Apr;59(4):573-7. doi: 10.1038/bjc.1989.116.
9
Expression of the genes of interferons and other cytokines in normal and diseased tissues of man.
Experientia. 1989 Jun 15;45(6):526-35. doi: 10.1007/BF01990502.
10
The altered expression of MHC-class II determinants on monocytes of cancer patients.
Cancer Immunol Immunother. 1988;27(2):171-6. doi: 10.1007/BF00200023.
本文引用的文献
1
Interleukin 1 is more than an interleukin.
Immunol Today. 1982 Apr;3(4):113-9. doi: 10.1016/S0167-5699(82)80027-3. Epub 2007 Sep 18.
2
Molecular mechanisms in tumor-cell killing by activated macrophages.
Immunol Today. 1983 Jun;4(6):166-70. doi: 10.1016/0167-5699(83)90005-1.
3
Macrophage activation for tumor cytotoxicity: characterization of priming and trigger signals during lymphokine activation.
J Immunol. 1981 Jul;127(1):179-83.
4
5
6
Cooperation between mononuclear phagocytes and lymphocytes in immunity.
N Engl J Med. 1980 Oct 23;303(17):977-85. doi: 10.1056/NEJM198010233031706.
7
Production of lymphocyte-activating factor (Interleukin 1) by macrophages activated with colony-stimulating factors.
J Immunol. 1980 Sep;125(3):1302-5.
8
Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing.
J Immunol. 1983 May;130(5):2011-3.
9
Interferons as macrophage-activating factors. II. Enhanced secretion of interleukin 1 by lipopolysaccharide-stimulated human monocytes.
Eur J Immunol. 1983 Jun;13(6):437-40. doi: 10.1002/eji.1830130602.
Zotero 插件